POCT Diagnostic Platform

Eaglenos Sciences, Inc.

Nanjing, China

About Eaglenos Eaglenos Sciences, Inc., founded in 2018, specializes in the development, manufacturing and marketing of point-of-care diagnostic devices for nearpatient testing and home care. Powered by cutting edge technologies in electrochemistry, microfluidics, signal acquisition, and automation, Eaglenos has quickly become a leading force in precise POCT products targeting diabetes, hyperuricemia, cardiovascular, cerebrovascular diseases and acute care testing. We have successfully launched blood gas analysis system, electrolyte analysis system, blood glucose/lactate/ketone/uric acid/ total cholesterol/creatinine test systems, and most recently continuous monitoring devices. Eaglenos has since obtained the ISO system certification, more than 20 NMPA certificates, FDA device listing, CE IVDD others and IVDR A certificates. Inspired by our core values of “quality, innovation, cooperation and accountability” , Eaglenos is committed to providing top quality diagnostic products and digital systems for a better, healthier life. What we do Eaglenos specializes in developing diagnostic devices tailored for home care and bedside testing. From acute care blood testing systems, to selfmonitoring meters and wearable devices for chronic diseases, our product lineup includes blood gas biochemical analyzers, electrolyte analyzers, versatile meters for blood glucose, lactate, ketone, creatinine, total cholesterol, and uric acid, as well as continuous glucose monitoring devices. Eaglenos electrochemical technology is distinguished by its unparalleled sensitivity, stability, rapid detection time, and minimal sample requirements. It seamlessly incorporates intricate functional elements from analytical laboratories into compact devices, ensuring an expeditious and user-friendly experience.